S21 - Epilepsy and Clinical Neurophysiology (EEG) I

Event Time: Tuesday April 25, 2017 1:00 pm to 3:00 pm
Topic(s): Epilepsy/Clinical Neurophysiology (EEG)
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Cannabidiol (CBD) significantly reduces drop seizure frequency in Lennox–Gastaut syndrome (LGS): results of a multi-center, randomized, double–blind, placebo controlled trial (GWPCARE4) Jacqueline French
Disclosure:
Dr. French has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen.

1:12 PM 002 Neurological Autoantibody Prevalence in Epilepsy of Unknown Etiology - APE Study Divyanshu Dubey, MD
Disclosure:
Dr. Dubey has nothing to disclose.

1:24 PM 003 Relationship between Cognitive Performance and Subjective Symptoms in Patients with Newly Diagnosed Focal Epilepsy Kimford Meador, MD, FAAN
Disclosure:
Dr. Meador has received research support from Sunovion Pharmaceuticals.

1:36 PM 004 Long-term safety and efficacy of responsive brain stimulation in adults with medically intractable partial onset seizures Dileep Nair, MD
Disclosure:
Dr. Nair has nothing to disclose.

2:00 PM 005 Post-Diagnosis Neurological Care for Patients with Psychogenic Nonepileptic Spells (PNES) Chloe Hill
Disclosure:
Dr. Hill has nothing to disclose.

2:12 PM 006 To Reveal or Conceal? Adult Patient Perspectives on SUDEP Disclosure. Lucretia Long
Disclosure:
Dr. Long has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Lina Nova, Sunovion Pharmceuticals , and Supernus Pharmaceuticals.

2:24 PM 007 Antibodies to neuronal surface antigens in possible autoimmune encephalitis and new-onset refractory status epilepticus (NORSE) Takahiro Iizuka, MD
Disclosure:
Dr. Iizuka has nothing to disclose.

2:36 PM 008 Chronic Cortical Electrode Stimulation is Effective for Focal Epilepsy Brian Lundstrom, MD
Disclosure:
Dr. Lundstrom has nothing to disclose.

Register Now

Related Courses